购物车
- 全部删除
- 您的购物车当前为空
Enarodustat (JTZ-951) 是口服具有活力的 hypoxia-inducible factor prolyl hydroxylase 抑制剂,EC50=0.22 μM,有用于肾性贫血症的研究潜力。
Enarodustat (JTZ-951) 是口服具有活力的 hypoxia-inducible factor prolyl hydroxylase 抑制剂,EC50=0.22 μM,有用于肾性贫血症的研究潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 298 | 现货 | |
2 mg | ¥ 428 | 现货 | |
5 mg | ¥ 688 | 现货 | |
10 mg | ¥ 1,150 | 现货 | |
25 mg | ¥ 1,980 | 现货 | |
50 mg | ¥ 3,320 | 现货 | |
100 mg | ¥ 4,880 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 778 | 现货 |
产品描述 | Enarodustat (JTZ-951) is an orally active factor inhibitor of prolyl hydroxylase (EC50: 0.22 μM) and has the potential for renal anemia treatment. |
靶点活性 | Factor prolyl hydroxylase:(EC50)0.22 μM |
体外活性 | Enarodustat exhibits neither CYP (IC50 > 100 μM; CYP3A4/5, CYP2C9, CYP2D6, CYP1A2, CYP2A6, CYP2C19, CYP2C8, CYP2B6) nor hERG (IC50 > 100 μM) inhibition. |
体内活性 | Enarodustat (1 and 3 mg/kg, p.o., in rats) treatment increases hemoglobin levels in a dose-dependent manner. |
别名 | JTZ-951 |
分子量 | 340.33 |
分子式 | C17H16N4O4 |
CAS No. | 1262132-81-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 83.33 mg/mL (244.85 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.